Recent Posts
- ScaleReady Announces a G-Rex® Grant has been awarded to Xellera Therapeutics
- Cell Therapies and Xellera Therapeutics Enter into a Strategic Partnership to Fast-Track Access to Cell and Gene Therapies across APAC
- The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommends Novartis’ CAR T-cell therapy for follicular lymphoma
- Decade-Long Remission After CAR T-cell therapy reported
- Xellera Therapeutics Launched Hong Kong’s First Current Good Manufacturing Practice (cGMP) Facility For Cell & Gene Therapy Products
Recent Comments
No comments to show.